88 related articles for article (PubMed ID: 21749394)
41. Cytogenetic evaluation for genotoxicity of bisphenol-A in bone marrow cells of Swiss albino mice.
Naik P; Vijayalaxmi KK
Mutat Res; 2009 May; 676(1-2):106-12. PubMed ID: 19393337
[TBL] [Abstract][Full Text] [Related]
42. Antimutagenic activity of ipriflavone against the DNA-damage induced by cyclophosphamide in mice.
Delarmelina JM; Dutra JC; Batitucci Mdo C
Food Chem Toxicol; 2014 Mar; 65():140-6. PubMed ID: 24389340
[TBL] [Abstract][Full Text] [Related]
43. Antimutagenic effect of Agaricus blazei Murrill mushroom on the genotoxicity induced by cyclophosphamide.
Delmanto RD; de Lima PL; Sugui MM; da Eira AF; Salvadori DM; Speit G; Ribeiro LR
Mutat Res; 2001 Sep; 496(1-2):15-21. PubMed ID: 11551476
[TBL] [Abstract][Full Text] [Related]
44. Mutagenicity of ipriflavone in vivo and in vitro.
Belcavello L; Vencioneck Dutra JC; de Freitas JV; Aranha IP; do Carmo Pimentel Batitucci M
Food Chem Toxicol; 2012 Mar; 50(3-4):996-1000. PubMed ID: 22200590
[TBL] [Abstract][Full Text] [Related]
45. Study on the mutagenicity and antimutagenicity of a natural food colour (annatto) in mouse bone marrow cells.
Alves de Lima RO; Azevedo L; Ribeiro LR; Salvadori DM
Food Chem Toxicol; 2003 Feb; 41(2):189-92. PubMed ID: 12480296
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of the general suitability of the rat for the micronucleus assay: the effect of cyclophosphamide in 14 strains.
Hamada S; Yamasaki KI; Nakanishi S; Omori T; Serikawa T; Hayashi M
Mutat Res; 2001 Aug; 495(1-2):127-34. PubMed ID: 11448650
[TBL] [Abstract][Full Text] [Related]
47. Bone marrow genotoxicity of 2,5-dimethylfuran, a green biofuel candidate.
Fromowitz M; Shuga J; Wlassowsky AY; Ji Z; North M; Vulpe CD; Smith MT; Zhang L
Environ Mol Mutagen; 2012 Jul; 53(6):488-91. PubMed ID: 22730236
[TBL] [Abstract][Full Text] [Related]
48. Further evidence for the rodent bone marrow micronucleus assay acting as a sensitive predictor of the possible germ cell mutagenicity of chemicals.
Tinwell H; Brinkworth MH; Ashby J
Mutat Res; 2001 Feb; 473(2):259-61. PubMed ID: 11166043
[No Abstract] [Full Text] [Related]
49. In vitro metabolism of the lignan (-)-grandisin, an anticancer drug candidate, by human liver microsomes.
Barth T; Habenschus MD; Lima Moreira F; Ferreira Lde S; Lopes NP; Moraes de Oliveira AR
Drug Test Anal; 2015 Sep; 7(9):780-6. PubMed ID: 25594619
[TBL] [Abstract][Full Text] [Related]
50. Protective effect of the yeast glucomannan against cyclophosphamide-induced mutagenicity.
Chorvatovicová D; Machová E; Sandula J; Kogan G
Mutat Res; 1999 Jul; 444(1):117-22. PubMed ID: 10477345
[TBL] [Abstract][Full Text] [Related]
51. Protective effects of common anthocyanidins against genotoxic damage induced by chemotherapeutic drugs in mice.
Khandelwal N; Abraham SK
Planta Med; 2014 Oct; 80(15):1278-83. PubMed ID: 25184891
[TBL] [Abstract][Full Text] [Related]
52. Modulation of cyclophosphamide mutagenicity by vitamin C in the in vivo rodent micronucleus assay.
Ghaskadbi S; Rajmachikar S; Agate C; Kapadi AH; Vaidya VG
Teratog Carcinog Mutagen; 1992; 12(1):11-7. PubMed ID: 1354896
[TBL] [Abstract][Full Text] [Related]
53. Genotoxic and Mutagenic Activity of PT-31.
Neto MP; Gomes DC; Júnior AL; Paz MF; Alencar MV; Islam MT; Ferreira PM; Melo-Cavalcante AA
Curr Pharm Biotechnol; 2016; 17(12):1043-1048. PubMed ID: 27526694
[TBL] [Abstract][Full Text] [Related]
54. [Decrease of mutagenic action of cyclophosphamide by buckwheat melanin preparation].
Baraboĭ VA; Durnev AD; Oreshchenko AV; Alekseeva TN; Ogarkov VN; Samusenok LV; Pestunovich VA
Ukr Biokhim Zh (1999); 2004; 76(5):148-50. PubMed ID: 16100912
[TBL] [Abstract][Full Text] [Related]
55. The protective effect of Canova homeopathic medicine in cyclophosphamide-treated non-human primates.
Leal MF; Antunes LM; Lamarão MF; da Silva CE; da Silva ID; Assumpção PP; Andrade EF; Rezende AP; Imbeloni AA; Muniz JA; Pinto GR; Smith Mde A; Burbano RR
Food Chem Toxicol; 2012 Dec; 50(12):4412-20. PubMed ID: 22982473
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the genotoxicity and mutagenicity of Ca3SiO5-based cement.
Nai GA; Logar Gde A; Mori GG; Teixeira LM; Silva BC; Moraes AE; Cabral FA
Braz Oral Res; 2016 Aug; 30(1):. PubMed ID: 27556557
[TBL] [Abstract][Full Text] [Related]
57. Conventional (MG-BR46 Conquista) and transgenic (BRS Valiosa RR) soybeans have no mutagenic effects and may protect against induced-DNA damage in vivo.
Venâncio VP; Silva JP; Almeida AA; Brigagão MR; Azevedo L
Nutr Cancer; 2012; 64(5):725-31. PubMed ID: 22662908
[TBL] [Abstract][Full Text] [Related]
58. The effect of apigenin on cyclophosphamide and doxorubicin genotoxicity in vitro and in vivo.
Bokulić A; Garaj-Vrhovac V; Brajsa K; Ethurić K; Glojnarić I; Situm K
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2011; 46(5):526-33. PubMed ID: 21469013
[TBL] [Abstract][Full Text] [Related]
59. In vivo antimutagenic and antiatherogenic effects of the (1 → 3)(1 → 6)-β-d- glucan botryosphaeran.
Silva-Sena GG; Malini M; Delarmelina JM; Dutra JCV; Gervásio SV; Leal MAS; Costa Pereira TM; Barbosa-Dekker AM; Dekker RFH; de Paula F; Batitucci MDCP
Mutat Res Genet Toxicol Environ Mutagen; 2018 Feb; 826():6-14. PubMed ID: 29412871
[TBL] [Abstract][Full Text] [Related]
60. (-)-Grandisin form Cryptocarya crassinervia.
Saad JM; Soepadamo E; Fang XP; McLaughlin JL; Fanwick PE
J Nat Prod; 1991; 54(6):1681-3. PubMed ID: 1812217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
